EARNINGS & TRADING: Microsalt lowers sales 2026 guidance
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 6.35p on 30-06-2026 at 13:35:15 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.50p |
| Sell | 6.20p |
| Last Trade: | Buy 15.00 at 6.50p |
| Day's Volume: | 8,864 |
| Last Close: | 6.35p |
| Open: | 6.35p |
| ISIN: | GB00BP0RTP38 |
| Day's Range | 6.35p - 6.35p |
| 52wk Range: | 4.60p - 13.25p |
| Market Capitalisation: | £6.56m |
| VWAP: | 6.203015p |
| Shares in Issue: | 103.30m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
OptiBiotix Health (OPTI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 15 | 6.50p | Ordinary |
10:45:21 - 30-Jun-26 |
| Sell* | 889 | 6.225p | Ordinary |
10:22:41 - 30-Jun-26 |
| Sell* | 15 | 6.20p | Ordinary |
10:08:18 - 30-Jun-26 |
| Sell* | 7,800 | 6.20p | Ordinary |
08:15:04 - 30-Jun-26 |
| Sell* | 145 | 6.20p | Ordinary |
08:02:41 - 30-Jun-26 |
| Sell* | 236 | 6.20p | Ordinary |
15:52:18 - 29-Jun-26 |
| Unknown* | 211,588 | 6.20p | Negotiated Trade |
09:48:06 - 29-Jun-26 |
| Buy* | 3,320 | 6.491p | Ordinary |
09:09:41 - 29-Jun-26 |
| Sell* | 329 | 6.225p | Ordinary |
08:30:52 - 29-Jun-26 |
| Buy* | 2,933 | 6.494p | Ordinary |
08:07:27 - 29-Jun-26 |
OptiBiotix Health (OPTI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jun 2026 3:00 pm | RNS-R | Investor presentation and Q&A |
| 23rd Jun 2026 4:25 pm | RNS | Result of AGM |
| 2nd Jun 2026 7:00 am | RNS-R | Investor presentation and SweetBiotix® Sampling |
| 29th May 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 28th May 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 14th May 2026 7:00 am | RNS-R | SweetBiotix® Sampling |
| 5th May 2026 2:30 pm | RNS | Holding(s) in Company |
| 1st May 2026 12:00 pm | RNS | Partial Disposal of Shares in SkinBioTherapeutics |
| 1st Apr 2026 7:00 am | RNS | Trading Update |
| 24th Feb 2026 7:00 am | RNS | WellBiome® clinical trial on surgical outcomes |